Your session is about to expire
← Back to Search
Procedure
MRI for Non-alcoholic Fatty Liver Disease (AWLS Trial)
N/A
Waitlist Available
Led By Kathleen Corey, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 months
Awards & highlights
AWLS Trial Summary
This study is evaluating whether weight loss surgery (WLS) can improve NAFLD in adolescents.
Eligible Conditions
- Non-alcoholic Fatty Liver Disease
- Obesity
AWLS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 7 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in hepatitis steatosis after weight loss surgery
AWLS Trial Design
1Treatment groups
Experimental Treatment
Group I: MRI for steatosis assessmentExperimental Treatment1 Intervention
Abdominal MRI for assessment of hepatic steatosis
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,933 Previous Clinical Trials
13,198,499 Total Patients Enrolled
15 Trials studying Non-alcoholic Fatty Liver Disease
847 Patients Enrolled for Non-alcoholic Fatty Liver Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,359 Previous Clinical Trials
4,315,492 Total Patients Enrolled
47 Trials studying Non-alcoholic Fatty Liver Disease
9,972 Patients Enrolled for Non-alcoholic Fatty Liver Disease
Kathleen Corey, MDPrincipal InvestigatorMassachusetts General Hospital
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger